SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-001157
Filing Date
2024-01-08
Accepted
2024-01-08 16:45:00
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4533
  Complete submission text file 0001209191-24-001157.txt   6064
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 98195-2141
Business Address
MOEBIUS HANS (Reporting) CIK: 0001822494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 24520757